FLNA 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-29

• Research and development expenses were $7.8 million and $18.8 million during the six months ended June 30, 2026 and 2025, respectively. This 58% decrease was due primarily to the phase out of the Alzheimer's disease development program, which was completed in the second quarter of 2025.

• General and administrative expenses were $12.7 million and $51.2 million during the six months ended June 30, 2026 and 2025, respectively. The 75% decrease was due primarily to a $31.3 million securities litigation loss contingency and other legal loss contingencies of $3.0 million recorded in the f…

• Interest income was $1.5 million and $2.5 million during the six months ended June 30, 2026 and 2025, respectively. The decrease in interest income was due primarily to lower interest rates and cash balances in 2026 compared to 2025.

• We expect interest income to decrease in future quarters as we continue to utilize cash in our operations.

• We record the activities related to leasing office space to third parties in buildings we own as other income (loss), net, as leasing is not core to the Company’s operations. Other income (loss), net, was $43,000 and $(46,000) during the three months ended June 30, 2026 and 2025, respectively.

相对上期删除的文字 · 来源:10-Q · 2026-05-07

• The Company is working expeditiously to address the items identified in the letter. However, as announced on December 18, 2025, the Company no longer expects to initiate a proof-of-concept clinical trial for simufilam in TSC-related epilepsy in the first half of 2026. The updated timing for initiati…

• We expect interest income to decrease in future quarters as we utilize cash in our operations and realize the impact of a lower interest rate environment.

• We record the activities related to leasing office space to third parties in buildings we own as other income (loss), net, as leasing is not core to the Company’s operations. Other income (loss), net, was $48,000 and $(82,000) during the three months ended March 31, 2026 and 2025, respectively.

• We recorded other income in the three months ended March 31, 2026 due to improved occupancy rates in 2026 compared to the prior year period. We expect to record modest net income on leasing activities in 2026 due to improved occupancy.